Literature DB >> 18202227

Repression via the GATA box is essential for tissue-specific erythropoietin gene expression.

Naoshi Obara1, Norio Suzuki, Kibom Kim, Toshiro Nagasawa, Shigehiko Imagawa, Masayuki Yamamoto.   

Abstract

In response to anemia, erythropoietin (Epo) gene transcription is markedly induced in the kidney and liver. To elucidate how Epo gene expression is regulated in vivo, we established transgenic mouse lines expressing green fluorescent protein (GFP) under the control of a 180-kb mouse Epo gene locus. GFP expression was induced by anemia or hypoxia specifically in peritubular interstitial cells of the kidney and hepatocytes surrounding the central vein. Surprisingly, renal Epo-producing cells had a neuronlike morphology and expressed neuronal marker genes. Furthermore, the regulatory mechanisms of Epo gene expression were explored using transgenes containing mutations in the GATA motif of the promoter region. A single nucleotide mutation in this motif resulted in constitutive ectopic expression of transgenic GFP in renal distal tubules, collecting ducts, and certain populations of epithelial cells in other tissues. Since both GATA-2 and GATA-3 bind to the GATA box in distal tubular cells, both factors are likely to repress constitutively ectopic Epo gene expression in these cells. Thus, GATA-based repression is essential for the inducible and cell type-specific expression of the Epo gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202227     DOI: 10.1182/blood-2007-10-115857

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  82 in total

1.  Inducible glomerular erythropoietin production in the adult kidney.

Authors:  Katharina Gerl; Lucile Miquerol; Vladimir T Todorov; Christian P M Hugo; Ralf H Adams; Armin Kurtz; Birgül Kurt
Journal:  Kidney Int       Date:  2015-09-23       Impact factor: 10.612

2.  A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism.

Authors:  Patrick R Arsenault; Fei Pei; Rebecca Lee; Heddy Kerestes; Melanie J Percy; Brian Keith; M Celeste Simon; Terence R J Lappin; Tejvir S Khurana; Frank S Lee
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

Review 3.  Physiology of the Renal Interstitium.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-26       Impact factor: 8.237

Review 4.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

5.  Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements.

Authors:  Ikuo Hirano; Norio Suzuki; Shun Yamazaki; Hiroki Sekine; Naoko Minegishi; Ritsuko Shimizu; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

Review 6.  Hypoxic regulation of erythropoiesis and iron metabolism.

Authors:  Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-05

Review 7.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

Review 8.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

Review 9.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

10.  Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range.

Authors:  Silverio Perrotta; Daniel P Stiehl; Francesca Punzo; Saverio Scianguetta; Adriana Borriello; Debora Bencivenga; Maddalena Casale; Bruno Nobili; Silvia Fasoli; Adriana Balduzzi; Lilla Cro; Katarzyna J Nytko; Roland H Wenger; Fulvio Della Ragione
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.